Wuhan Hvsen Biotechnology Co.,Ltd. (SHE:300871)
China · Delayed Price · Currency is CNY 27.18
+0.27 (1.00%)
Jan 23, 2026, 3:04 PM CST
Wuhan Hvsen Biotechnology Market Cap
Wuhan Hvsen Biotechnology has a market cap or net worth of 5.48 billion as of January 23, 2026. Its market cap has increased by 220.18% in one year.
Market Cap
5.48B
Enterprise Value
5.31B
Revenue
1.67B
Ranking
n/a
PE Ratio
22.79
Stock Price
27.18
Market Cap Chart
Since August 24, 2020, Wuhan Hvsen Biotechnology's market cap has decreased from 6.83B to 5.48B, a decrease of -19.84%. That is a compound annual growth rate of -4.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 5.48B | 31.11% |
| Dec 31, 2025 | 4.18B | 151.73% |
| Dec 31, 2024 | 1.66B | -29.78% |
| Dec 29, 2023 | 2.36B | -29.56% |
| Dec 30, 2022 | 3.36B | -29.11% |
| Dec 31, 2021 | 4.73B | 7.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beijing Konruns Pharmaceutical | 6.93B |
| R&G PharmaStudies | 6.85B |
| Kexing Biopharm | 6.67B |
| PharmaResources (Shanghai) | 6.50B |
| Jiangsu Bioperfectus Technologies | 6.48B |
| Xiangxue Pharmaceutical | 6.43B |
| Shanghai OPM Biosciences | 6.34B |
| Novogene | 5.98B |